GENE ONLINE|News &
Opinion
Blog

2019-10-01| Asia-Pacific

Weekly in Asia|SEP-3

by GeneOnline
Share To

20190923-0929 Weekly in Asia

Eisai and Tokio Marine Nichido Form Business Alliance to Tackle Dementia

The worldwide population is aging rapidly; countries are facing ongoing challenges in caring for their elderly. It is predicted that one out of five elderly people over the age of 65 will have dementia in Japan.

Japanese firm Eisai Co., Ltd. and Tokio Marine & Nichido Fire Insurance Co., Ltd. have announced on September 26th that the companies have entered into a business alliance agreement for co-existence and prevention of dementia, including dementia disease awareness initiatives.

Under the agreement, initiatives such as “disease awareness initiatives”, “environment development”, and “measures to familiarize insurance product” are scheduled. The two companies will utilize Eisai’s abundant experience and knowledge of medicine creation and disease awareness activities in dementia as well as Tokio Marine Nichido’s expertise and networks cultivated in its insurance products and related services.

 

About Eisai

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. The company positions oncology as a key therapeutic area and is aiming to discover revolutionary new medicines with the potential to cure cancer.

 

About Tokio Marine & Nichido Fire Insurance Co., Ltd.

Tokio Marine & Nichido Fire Insurance Co., Ltd. has provided a variety of insurance products and the related services to support the challenges of all individual and corporate customers.

 

Thermo Fisher Scientific Announces Collaboration with Frontier Biotechnologies Inc. and Expands Clinical Trials Capabilities

Thermo Fisher, the world leader in serving science and Frontier Biotechnologies, Inc., a biopharmaceutical company based in China, announced on September 26th a strategic partnership to accelerate the commercialization of 3BNC117, a novel broad-spectrum HIV neutralizing antibody. In addition, to align with China’s effort to encourage drug innovation, Thermo Fisher sets to expand its integrated clinical trials supply and distribution services network in Suzhou, China. The new facility will support the growth of clinical trial studies for customers in China and provide emerging biotech companies with the resources to develop and commercialize new drug candidates.

 

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science. The company helps customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity.

 

About Frontier Biotechnologies

Frontier Biotech is a research-based, clinical stage pharmaceutical company utilizing cross-Pacific drug discovery and development business model.

 

Thailand Lab International 2019 and BIO Investment Asia 2019 Took Place in Bangkok from September 25-27

It is widely believed that biotechnology and medical industry will become one of the key accelerators to move Thailand forward to become a value based and innovation driven economy. Thailand has the potential to become the medical hub for Southeast region.

Thailand Lab 2019, the 9th international trade exhibition and conference on analytical laboratory equipment and technology, was held from September 25th to 27th at Bangkok, in parallel with BIO Investment Asia 2019, the 6th International Tradeshow for BIO Business & Investment in Asia, which focuses on integrated solutions for bio economy & life sciences.

Thailand Lab International 2019 and BIO Investment Asia 2019 has covered biotechnology and medical platform synchronized with Thailand’s development and has successfully stimulated investments.

 

 

HTC Releases New AI platform DeepQ and VR Technology

2019 IEEE International Conference on Image Processing (ICIP 2019), the flagship international conference in the field of image processing in the IEEE Society, was held in Taiwan for the first time in 26 years, from September 22-25, 2019 at Taipei, Taiwan. Google, Facebook, Qualcomm, Tencent, Microsoft and other technology giants all participated. HTC’s healthcare division also attended the conference and unveiled the latest medical imaging platform, the DeepQ AI platform. Edward Chang, President of Research and Healthcare (DeepQ) at HTC, pointed out that, instead of investing a lot of labor, the best way to implement AI in the practical medical industry is to “let AI master AI”. As AI tools become smarter, medical staff can leverage their clinical experience and knowledge to lead the development of deep learning models. When every doctor can build his own AI application, there will be a thorough change. In addition to AI, DeepQ has made significant breakthroughs in medical surgery, educational Virtual Reality (VR) technology and blockchain technology. DeepQ’s products for medical VR-assisted brain tumors have been licensed by the Ministry of Health and Welfare, showing its potential in medical applications. MedXchange, a medical information exchange platform developed jointly with Stanford University and National Taiwan University, has been tested at Stanford University School of Medicine.

 

GOLiFE Cuts Into the Smart Medical Market by Collaborating with Cloudmed to Approach the Reproductive Medicine Field

According to statistics from the World Health Organization (WHO), the proportion of infertility in countries around the world is about 8-12%. Take China’s assisted reproductive market as an example. In 2016, it has reached about 18.5 billion yuan (RMB) and maintained growth rate of more than 20%. It is estimated that by 2020, the market capacity of assisted reproduction will exceed USD 5.6 billion.

GOLiFE announced on September 19th that it has jointly developed the “QPID Reproductive Medicine Work Management System” with Cloudmed to meet the needs of reproductive medicine.

The two companies only completed the establishment of the cross-departmental process management system, but also developed the “AI Embryo Quality Recommendation System”. The system can automatically mark and score embryos and provide physicians clinical decision aid. The platform was launched at the Huayu Reproductive Medicine Center in September.

 

About GOLiFE

GOLiFE Inc was founded in 2008 and is a subsidiary of PAPAGO. The company provides online map service, cloud service and data support associated with mobile application on smart devices.

 

About Cloudmed
Founded in 2018, Cloudmed is headquartered in Hsinchu and has branches in the United States and Hong Kong. Cloudmed is the first company to provide services of professional integrated medical service solution and has been a pioneer in Taiwan’s professional mobile medical electronics manufacturing and mobile health management services.

 

References

  1. https://www.eisai.com/news/2019/news201974.html
  2. https://finance.yahoo.com/news/thermo-fisher-scientific-expands-clinical-060000867.html
  3. http://www.thailandlab.com/
  4. http://www.bioinvestmentasia.com/#factsheet
  5. https://deepq.com/htc-deepq-ai-platform/
  6. https://ec.ltn.com.tw/article/breakingnews/2921085

 

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
M&A
Thermo Fisher Announces the Multi-Billion Dollar Acquisition of The Binding Site Group
2022-10-31
Thermo Fisher Announces $59 Million Lab Expansion In Kentucky, Reveals AI Deal With Genoox
2022-10-28
Eisai Touts Lenvima Efficacy In Thyroid Cancer Study
2022-10-24
LATEST
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
Scientists Identify New Genetic Variant Related to Obesity
2022-12-01
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
2022-12-01
FDA Revokes Authorization Of Eli Lilly’s COVID-19 Antibody
2022-12-01
Eisai Unveils Lecanemab Data Following Reports of Second Alzheimer’s Patient Death
2022-11-30
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
2022-11-30
Gland Pharma Dispels Rumors Of Fosun Sale, Acquires Cenexi In Separate Development
2022-11-30
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!